Edinburgh Biosciences Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.01M

  • Investors
  • 4

Edinburgh Biosciences General Information

Description

Developer of a cataract treatment technology intended to provide an alternative to surgery with a non-invasive treatment. The company's device focuses light onto the affected lens, reducing opacity, and monitoring changes in the lens by measuring the light emitted from the protein aggregates when excited with ultraviolet rays, enabling businesses to have access to treat cataracts with light treatment and providing information on its effectiveness.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 4B Gateway Business Park
  • Beancross Road
  • Grangemouth FK3 8WX
  • Scotland, United Kingdom
+44 01506
Primary Industry
Other Healthcare Technology Systems
Other Industries
Monitoring Equipment
Therapeutic Devices
Vertical(s)
Corporate Office
  • Unit 4B Gateway Business Park
  • Beancross Road
  • Grangemouth FK3 8WX
  • Scotland, United Kingdom
+44 01506

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edinburgh Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 29-Apr-2025 $3.01M Completed Generating Revenue
5. Later Stage VC (Series A) 01-Jul-2021 Completed Generating Revenue
4. Seed Round 17-Sep-2020 Completed Generating Revenue
3. Grant 01-Jul-2019 Completed Generating Revenue
2. Grant 01-May-2018 $654K Completed Generating Revenue
1. Grant 01-Dec-2014 $161K Completed Generating Revenue
To view Edinburgh Biosciences’s complete valuation and funding history, request access »

Edinburgh Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 332,399 $1.306729 $4.3 $4.3 1x $4.3 14.97%
To view Edinburgh Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Edinburgh Biosciences Patents

Edinburgh Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021422913-A1 Apparatus and systems for monitoring and treating cataracts Pending 26-Jan-2021
EP-4284230-A1 Apparatus and systems for monitoring and treating cataracts Active 26-Jan-2021
EP-4284230-B1 Apparatus and systems for monitoring and treating cataracts Active 26-Jan-2021
ES-3025137-T3 Apparatus and systems for monitoring and treating cataracts Active 26-Jan-2021
GB-202101007-D0 Apparatus and systems for monitoring and treating cataracts Active 26-Jan-2021 A61B3/13
To view Edinburgh Biosciences’s complete patent history, request access »

Edinburgh Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edinburgh Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Haoguang Venture Capital Minority
Highland Venture Capital Angel Group Minority
Innovate UK Government
UK Research and Innovation Government
To view Edinburgh Biosciences’s complete investors history, request access »

Edinburgh Biosciences FAQs

  • When was Edinburgh Biosciences founded?

    Edinburgh Biosciences was founded in 2003.

  • Where is Edinburgh Biosciences headquartered?

    Edinburgh Biosciences is headquartered in Grangemouth, United Kingdom.

  • What is the size of Edinburgh Biosciences?

    Edinburgh Biosciences has 10 total employees.

  • What industry is Edinburgh Biosciences in?

    Edinburgh Biosciences’s primary industry is Other Healthcare Technology Systems.

  • Is Edinburgh Biosciences a private or public company?

    Edinburgh Biosciences is a Private company.

  • What is the current valuation of Edinburgh Biosciences?

    The current valuation of Edinburgh Biosciences is .

  • What is Edinburgh Biosciences’s current revenue?

    The current revenue for Edinburgh Biosciences is .

  • How much funding has Edinburgh Biosciences raised over time?

    Edinburgh Biosciences has raised $7.6M.

  • Who are Edinburgh Biosciences’s investors?

    Haoguang, Highland Venture Capital, Innovate UK, and UK Research and Innovation have invested in Edinburgh Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process